SCHEMBL30847342

SCHEMBL30847342

FC(F)(F)c1cccc(Nc2nccc(-c3c[nH]c4cnccc34)n2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 1/20 0.57
EGFR P00533 1/20 0.57
BCR P11274 1/20 0.57
SRC P12931 1/20 0.57
PRKCA P17252 1/20 0.57
PRKACA P17612 1/20 0.57
PRKACG P22612 1/20 0.57
PRKACB P22694 1/20 0.57
PRKCD Q05655 1/20 0.57
CDK2 P24941 9/20 0.55
GSK3B P49841 7/20 0.55
AURKA O14965 2/20 0.54
CDK4 P11802 1/20 0.53
DYRK1A Q13627 5/20 0.52
DYRK1B Q9Y463 3/20 0.52
CLK1 P49759 1/20 0.52
CLK2 P49760 1/20 0.52
CLK4 Q9HAZ1 1/20 0.52
NFATC1 O95644 1/20 0.51
CCNB2 O95067 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27109944 1.00 ABL1 (0.57) ABL1EGFRBCRSRCPRKCA
SCHEMBL13051119 0.86 ABL1 (0.55) ABL1EGFRBCRSRCPRKCA
SCHEMBL13051120 0.84 ABL1 (0.58) ABL1EGFRBCRSRCPRKCA
SCHEMBL2542944 0.84 CCNB2 (0.67) ABL1EGFRBCRSRCPRKCA
SCHEMBL13051126 0.82 DYRK1B (0.60) ABL1EGFRBCRSRCPRKCA
SCHEMBL13051121 0.82 CDK2 (0.56) ABL1EGFRBCRSRCPRKCA
SCHEMBL13051124 0.82 EGFR (0.59) ABL1EGFRBCRSRCPRKCA
SCHEMBL3247348 0.79 AURKA (0.58) CDK2GSK3BAURKACDK4DYRK1A
SCHEMBL13051122 0.78 DYRK1B (0.52) ABL1EGFRBCRSRCPRKCA
SCHEMBL12723010 0.78 ABL1 (0.55) ABL1EGFRBCRSRCPRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024044757-A1 AMINOPYRIMIDINE AND AMINOTRIAZINE DERIVATIVES AS MYC PROTEIN MODULATORS Sanford Burnham Prebys Medical Discovery Institute (US) 2024-02-29 WO disclosed